Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery

• Status: Completed
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the safety and effectiveness of oculusgen (ologen) collagen matrix implantation and Mitomycin-C(MMC) in glaucoma surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pro Top & Mediking Company Limited
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• Open angle glaucoma

• Maxima anti-glaucoma medication failed

• Age>18

• Able to complete the follow up

Exclusion Criteria:

• Topical eye inflammation

• Angle closure glaucoma

• Deformity glaucoma

• One eye glaucoma

• Previous conjunctiva opened

• Allergy to collagen